Stockreport

Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept [Yahoo! Finance]

Opthea Limited - American Depositary Shares  (OPT) 
PDF Enrollment of second pivotal trial (ShORe) to complete in calendar Q2 2024 COAST and ShORe top-line results expected by mid-2025 MELBOURNE, Australia, Feb. 14, 2024 [Read more]